Novo Nordisk takes the field at the big game, putting Wegovy® pill in consumers’ hands
Novo Nordisk’s first big game spot introduces America to the FDA-approved Wegovy® pill — the first and only GLP-1…
DSV sells USA Truck, former DB Schenker subsidiary
The sale had already been planned for the third quarter of 2025. The new owner is UTAC, LLC,…
Blade Circularity
A breakthrough in the CETEC project has resulted in a new chemical process that makes epoxy-based turbine blades…
European onshore wind and PV business shifts from Ørsted to CIP
Copenhagen Infrastructure Partners, an energy infrastructure fund manager, has agreed to acquire Ørsted, a renewable energy developer, both…
Danske Bank Surpasses Profit Expectations Amidst Stabilizing Rates
Danske Bank’s fourth-quarter profits have exceeded expectations, signaling a robust performance against the backdrop of stabilizing interest rates…
Maersk Sank On Weaker Freight Rates And A Profit Miss
nagement’s guidance range (EBITDA $4.5 billion–$7.0 billion; EBIT from a $1.5 billion loss to a $1.0 billion profit)…
Novo Nordisk shares rebound after FDA warning on illegal weight-loss drugs: Copycat maker Hims and Hers responds
Shares of Novo Nordisk rose more than 5% in pre-market trading on Friday, after Hims & Hers Health…
Financial Outlook
Disclaimer and cautionary statement
This site contains forward-looking statements concerning Vestas’ financial condition, results of operations and business.…
Orsted Divests European Onshore Wind & Solar to CIP for $1.69B | 2026 – News and Statistics
Feb 3, 2026 Danish energy company Orsted has agreed to sell its entire European onshore business to Copenhagen…
Estonia puts Danske Bank settlement money into anti-corruption efforts
Tallinn, Estonia (Credit: Shutterstock/Boris Stroujko) The Estonian government will use $1.4 million of the $50 million received from…
A.P. Møller – Mærsk Shares Fall as Freight Rates Drag 2025 Earnings
A.P. Møller – Mærsk A/S is the world’s leading maritime transport company. The group’s activity is organized around…
Novo Nordisk Warning Tests Valuation As Pricing And Competition Intensify
Novo Nordisk (NYSE:NVO) has warned of a potential decline in sales and profit in 2026, citing intensifying US…